Alcohol and Metabolic Syndrome Interaction.
Alcohol
Fibrosis
Metabolic syndrome
Mortality
Steatosis
Journal
Clinics in liver disease
ISSN: 1557-8224
Titre abrégé: Clin Liver Dis
Pays: United States
ID NLM: 9710002
Informations de publication
Date de publication:
Nov 2024
Nov 2024
Historique:
medline:
4
10
2024
pubmed:
4
10
2024
entrez:
3
10
2024
Statut:
ppublish
Résumé
Alcohol-related liver disease and metabolic-dysfunction-associated steatotic liver disease are the most common causes of chronic liver disease. Globally, alcohol intake, and metabolic syndrome driven by excessive caloric intake and sedentary lifestyle have steadily increased over the past decades. Given the high prevalence rates of both excessive alcohol consumption and components of metabolic syndrome, both can frequently coexist in the same individuals and impact their lives. In this article, we review the impact of alcohol and metabolic syndrome on liver-related outcomes.
Identifiants
pubmed: 39362710
pii: S1089-3261(24)00050-3
doi: 10.1016/j.cld.2024.06.002
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
601-620Informations de copyright
Copyright © 2024 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure Dr Z. M. Younossi is a consultant to BMS, GSK, Cymabay, Ipsen, Abbott, Novo Nordisk, Madrigal, Merck, Siemens, and Intercept. Other authors have no conflict of interest to disclose.